Company Overview
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
Why Investors Should Care
Operating margin of 23.7% supports profitability.
Carries low leverage with a debt-to-equity ratio of 0.14.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $17.40B (+2.9% YoY); net profit $1.09B.
- Trailing 12 Months Year-on-year growth — revenue +11.0%, earnings +12.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 2.9%, profit CAGR 9.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 2.86% |
| 1 Year: | 11.00% |
Compounded Profit Growth
| 5 Years: | 9.94% |
| 1 Year: | 12.10% |
Stock Price Performance
| 1 Year: | +17.27% |
| 6 Months: | +24.25% |
| 3 Months: | +1.91% |
| 1 Month: | +13.43% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)59.85 · Neutral
P/E of 45.90 is above the sector median of 22.91 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CTVA Corteva, Inc. SPX | 84.91 | 45.90 | $56.79B | 0.95% | - | 5.14% | 2.86% | 9.94% |
| 2 | LIN Linde plc NDXSPX | 522.54 | 34.65 | $241.59B | 1.22% | 12.46% | 18.23% | 13.90% | 18.47% |
| 3 | NEM Newmont Corporation SPX | 94.75 | 12.29 | $101.15B | 1.04% | - | 25.83% | 6.53% | 20.15% |
| 4 | FCX Freeport-McMoRan Inc. SPX | 61.95 | 32.78 | $89.06B | 0.88% | 12.50% | 15.63% | 1.35% | -1.26% |
| 5 | SHW The Sherwin-Williams Company SPX | 328.50 | 31.56 | $81.02B | 1.01% | 21.93% | 60.72% | 6.18% | 8.26% |
| 6 | ECL Ecolab Inc. SPX | 269.75 | 36.55 | $75.92B | 1.10% | 14.29% | 22.43% | 6.17% | 9.18% |
| 7 | CRH CRH plc SPX | 103.91 | 19.28 | $69.43B | 1.47% | 10.97% | 15.81% | 6.41% | 9.30% |
| 8 | APD Air Products and Chemicals, Inc. SPX | 299.40 | 31.55 | $66.67B | 2.57% | -0.62% | 12.35% | -1.77% | -39.16% |
| 9 | DD DuPont de Nemours, Inc. SPX | 134.17 | 353.08 | $54.35B | 1.66% | 4.46% | 0.90% | -19.27% | -37.76% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.79B | 5.73B | 1.95B | 2.81B | 3.40B | 5.56B | 1.91B | 2.98B | 3.96B | 5.19B | 1.86B | 3.21B | 4.18B | 5.63B | 2.37B | 4.60B | 6.25B | 2.78B | 4.88B | 6.04B | 2.59B | 4.49B | 6.11B | 2.33B | 4.42B | 6.46B | 2.62B | 4.91B |
| Net Income | -107.00M | 694.00M | -5.12B | -531.00M | 164.00M | -608.00M | -494.00M | -21.00M | 272.00M | 760.00M | -392.00M | 41.00M | 600.00M | 970.00M | 30.00M | 564.00M | 969.00M | -331.00M | 595.00M | 714.00M | -321.00M | 419.00M | 1.05B | -524.00M | 652.00M | 1.31B | -320.00M | 720.00M |
| Diluted EPS | - | 0.92 | -6.83 | - | 0.22 | -0.81 | -0.66 | - | 0.36 | 1.01 | -0.52 | - | 0.80 | 1.31 | 0.04 | 0.78 | 1.33 | -0.46 | 0.83 | 1.00 | -0.45 | 0.60 | 1.51 | -0.76 | 0.95 | 1.92 | -0.47 | 1.07 |
| R&D Expense | 382.00M | 354.00M | 325.00M | - | 299.00M | 269.00M | 289.00M | - | 280.00M | 273.00M | 284.00M | - | 281.00M | 293.00M | 297.00M | 268.00M | 296.00M | 312.00M | 316.00M | 329.00M | 335.00M | 332.00M | 357.00M | 348.00M | 335.00M | 375.00M | 351.00M | 341.00M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.29B | 13.85B | 14.22B | 15.65B | 17.45B | 17.23B | 16.91B | 17.40B |
| Net Income | -5.07B | -959.00M | 681.00M | 1.76B | 1.15B | 735.00M | 907.00M | 1.09B |
| Diluted EPS | -6.76 | -1.28 | 0.91 | 2.37 | 1.58 | 1.03 | 1.30 | 1.60 |
| R&D Expense | 1.35B | 1.15B | 1.14B | 1.19B | 1.22B | 1.34B | 1.40B | 1.47B |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2016 | Aug 2017 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | - | 108.68B | 42.40B | 42.65B | 42.34B | 42.62B | 43.00B | 40.83B | 42.84B |
| Total Equity | 10.20B | 12.52B | 79.59B | 74.66B | 24.31B | 24.82B | 25.38B | 25.30B | 25.04B | 23.79B | 24.14B |
| Cash & Equivalents | - | - | - | 2.27B | 1.76B | 3.53B | 4.46B | 3.19B | 2.64B | 3.11B | 4.52B |
| Current Liabilities | - | - | - | 13.31B | 8.24B | 8.55B | 9.56B | 10.74B | 10.41B | 10.39B | 12.12B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 483.00M | 1.07B | 2.06B | 2.73B | 872.00M | 1.77B | 2.15B | 3.41B |
| Investing Cash Flow | -505.00M | -904.00M | -674.00M | -362.00M | -632.00M | -1.99B | -589.00M | -543.00M |
| Financing Cash Flow | -2.62B | -2.93B | 303.00M | -1.27B | -1.18B | -99.00M | -1.20B | -1.64B |
| Capital Expenditure | -1.50B | -1.16B | - | - | - | - | - | - |
| Free Cash Flow | -1.02B | -93.00M | - | - | - | - | - | - |
| Share Buybacks | 0 | 25.00M | 275.00M | 950.00M | 1.00B | 756.00M | 1.01B | 1.07B |
| Dividends Paid | 0 | -194.00M | -388.00M | 397.00M | 418.00M | 439.00M | 458.00M | 475.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | - |
| Net Margin % | -35.5% | -6.9% | 4.8% | 11.2% | 6.6% | 4.3% | 5.4% | 6.3% |
| ROE % | -6.8% | -3.9% | 2.7% | 6.9% | 4.5% | 2.9% | 3.8% | 4.5% |
| ROCE % | - | - | - | - | - | - | - | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 8.18% | 54.71M | $4.66B |
| 2 | Vanguard Capital Management LLC | 6.59% | 44.08M | $3.75B |
| 3 | State Street Corporation | 5.40% | 36.14M | $3.08B |
| 4 | Capital World Investors | 5.38% | 36.00M | $3.07B |
| 5 | FMR, LLC | 5.23% | 34.97M | $2.98B |
| 6 | Vanguard Portfolio Management LLC | 4.49% | 30.06M | $2.56B |
| 7 | Franklin Resources, Inc. | 3.26% | 21.79M | $1.86B |
| 8 | Aristotle Capital Management, LLC | 2.82% | 18.83M | $1.60B |
| 9 | Geode Capital Management, LLC | 2.80% | 18.72M | $1.59B |
| 10 | Harris Associates L.P. | 2.49% | 16.66M | $1.42B |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CTVA
Corteva (NYSE:CTVA) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQTHZ5b2VvSnVrczFqX3VtRlZobmVQMk5Bc3g2S1VadF9yN2xXSENCZmZFdEFkeUtXUXVMTTBoRDdQaTAyWnMyVVlCUUh4NEo0Smt1emx1WDlkOGtaVEFBbjFiQ0x1T0dKcTdrcmtVRXFvUDJRel8tWVhNMDdSajVrYkVNcmp4WUFNbENUU2…
CTVA Maintained by Mizuho -- Price Target Raised to $97.00 - GuruFocus
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOMEx0YXhzaWNWR2hFX1ZoRFRDZHNwRkcwRy1raHdSV0o4a0Zac1J1aWcwdkQ1MlFfMnVMbTZBOWlBU3Z3T1MxWkhpM3ByVDRtS0l0empRQmJVWk5Pc2F1YURScUItS0thVkFSZlhIQUFUbjI4em91Z2Z2YkVEYThpZTlYVkc3X3JpY282R0…
Is Corteva (CTVA) Stock Rich Or Reasonable As Breakups Near? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQQ2NIZkFYOTQtUldxRVhIZnN5RHRBWTN3ejZQcUNxVnMzclh5U01WUlE3M0hKeFljbTl2QUs1NGRzM2poOEFuQ3FmckJvODVHalVCUG5MT3pwaUxwX3lleFRIYjBzaDdsUWNFWTZRYTg4S3hxWDFBaXFTdzhFUXlqakcwRzdPZklaT3lHVj…
Is Corteva’s (CTVA) Arginex Soy Tie-Up a Subtle Shift in Its Innovation Playbook? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPaUo2UFhkTWpjZGpsWmI5NE1xUGtQOG15TmY0eHZaZktxdGNEMUVBV3MyVTFJSXI5NmJYakdkRTluLWVYWlhDSFplX1BWMG9jdkZVY1RZTFlXbjdLTXdxVGt0VGFwUU1hT0h6TFoxZ3RTbmNiX25KamxZSjZaakdvNWxTdEloUWVwSUk1OG…
Enterprise value to EBITDA forward of Corteva Inc – BMV:CTVA - TradingView
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxNeGQwZ1VmdHoza0tVaHNfQ2dyS1BHRG80YUZwMkdYclJjeUlRSGZpbVNiM1Z2ZnBhWUNHUzh5d1VFWExUbUZBeHBSYUVNMDRjZGFxR09qNU9WZF9JUHl0bjVLNk92ekN5cFcyNGNHYks2S3BSeWFGYnV1SWJ4TnAtSWhrSkNDS3prUmFhb0…
Corteva picks board for Vylor as seed spin-off stays on track for 4Q 2026 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOYW9VRGlJWXZqa1ZDNFBpLVhVQkVDNG1JREdTQWVWYjlKQjRiSWdtTXNJcDZ6NUFOdTJJQ2d1bm4yeUdyOUxNMzVmZmdJUW1kbHFfRzd0ZFp5X0c0MHRmSEZEYkx3S0xpSEliZVNQUkdiZVJDMHpvRVROb0x6eXFLZk9QbXg3ZHhFdTdURW…
CTVA — Frequently Asked Questions
What is the current share price of Corteva, Inc. (CTVA)?
As of 2026-07-14 21:23 PDT, Corteva, Inc. (CTVA) trades at $84.91 on NYSE. Its 52-week range is $60.56 to $86.75.
What is the market capitalisation of CTVA?
Corteva, Inc. (CTVA) has a market capitalisation of $56.79B on NYSE.
What is the P/E ratio of CTVA?
CTVA trades at a trailing price-to-earnings (P/E) ratio of 45.90. The industry average P/E is 22.91. Its price-to-book (P/B) ratio is 2.09.
Does CTVA pay a dividend?
Corteva, Inc. (CTVA) currently offers a dividend yield of 0.95%.
What is the return on equity (ROE) of CTVA?
CTVA has a return on equity (ROE) of 5.14%.
Is CTVA a good stock to buy?
This page provides a data-driven analysis of Corteva, Inc. (CTVA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.